In the latest interview of the Industry Insights series, we caught up with Andy Blackwell, Chief Scientific & Strategy Officer at Ieso Digital Health
Andy share his insights on the current climate of digital therapeutics and also his thoughts on the following:
How should digital therapeutics companies be working with patients to ensure that these products truly deliver on their promise of better care?
What impact do you expect Covid-19 to have on the long-term adoption of the digital therapeutics market?
What has the data shown you about the impact of Covid-19 on your patients?